Phathom Pharmaceuticals(PHAT) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Phathom Pharmaceuticals Price Target Cut to $12.00/Share From $18.00 by Goldman Sachs
Dow Jones13:46 ET · Ratings
Phathom Pharmaceuticals Is Maintained at Neutral by Goldman Sachs
Dow Jones13:46 ET · Ratings
Goldman Sachs Maintains Phathom Pharmaceuticals(PHAT.US) With Hold Rating, Maintains Target Price $12
Moomoo NewsMar 10 07:31 ET · Ratings
A Quick Look at Today's Ratings for Phathom Pharmaceuticals(PHAT.US), With a Forecast Between $12 to $28
Moomoo NewsMar 8 08:00 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Aziyo Biologics (ELUT) and IGM Biosciences (IGMS)
TipRanksMar 7 08:51 ET · Ratings
H.C. Wainwright Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Maintains Target Price $28
Moomoo NewsMar 7 06:31 ET · Ratings

Comments

Jaguar8

Yesterday 06:13

🟢Watchlist, MARCH 10,2025, Monday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...

49

5

Jaguar8

Mar 6 17:00

⚫️Watchlist, MARCH 7,2025, Friday. NFA -DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you...

48

28

4

Trytosaveabit

Mar 6 07:16

Pretty good

$Phathom Pharmaceuticals (PHAT.US)$ Fourth Quarter and Full Year 2024 Financial Results:

• Revenue: Net revenues for the fourth quarter 2024 were $29.7 million, an increase of $29.0 million compared to $0.7 million for fourth quarter 2023. Net revenues for the full year 2024 were $55.3 million, an increase of $54.6 million compared to $0.7 million in 2023. The increase was due to a full year of VOQUEZNA, VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK revenues following the commercial lau...

2

Jamesfongmm

Nov 12, 2024 10:04

$Phathom Pharmaceuticals (PHAT.US)$ what's going on?

Xyno

Oct 28, 2024 19:47

$Phathom Pharmaceuticals (PHAT.US)$ Earnings announced for November 7 and an immediate effect on the price.

PHAT Phathom Pharmaceuticals

Trade Overview

Capital Trend

News

Comments

Trending Stocks